Literature DB >> 2818923

Structure-activity relationships in differential nerve block at high and low frequency stimulation.

J A Wildsmith1, D T Brown, D Paul, S Johnson.   

Abstract

We have examined the in vitro sensitivities of A, B and C fibres in rabbit vagus nerves to local anaesthetic block with a range of local anaesthetic drugs. The nerves were maintained at 37 degrees C and pH 7.4 using an electrolyte solution equilibrated with 5% carbon dioxide. A fibres were the most, and C fibres the least, sensitive to block at low frequency stimulation (0.0167 Hz). Equipotent concentrations of the various drugs blocked C fibres at approximately the same rate. Rate of A fibre block was related to physicochemical properties of individual drugs. Low pKa and high lipid solubility favoured block of A fibres before C, whereas the reverse was true for high pKa and low solubility. Absolute potency was related to lipid solubility, but each type of local anaesthetic drug in clinical use has a different inherent potency. With stimulation at high frequencies (20 and 40 Hz), C fibres were more sensitive to use-dependent block than A fibres; this effect was more marked with drugs containing an amide than an ester linkage. Molecular size and lipid solubility may inter-react to govern the ability to produce use dependent block. Agents which contain an amide linking group, have a high pKa and are of low lipid solubility, may be used to produce differential C fibre block.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818923     DOI: 10.1093/bja/63.4.444

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  Anesthetic efficacy of different ropivacaine concentrations for inferior alveolar nerve block.

Authors:  Eman El-Sharrawy; John A Yagiela
Journal:  Anesth Prog       Date:  2006

Review 2.  Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia.

Authors:  Stephan A Schug; David Saunders; Irina Kurowski; Michael J Paech
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Ropivacaine: an update of its use in regional anaesthesia.

Authors:  K J McClellan; D Faulds
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

4.  Activity-dependent depression of neuronal sodium channels by the general anaesthetic isoflurane.

Authors:  K Purtell; K J Gingrich; W Ouyang; K F Herold; H C Hemmings
Journal:  Br J Anaesth       Date:  2015-07       Impact factor: 9.166

Review 5.  Benefit-risk assessment of ropivacaine in the management of postoperative pain.

Authors:  Wolfgang Zink; Bernhard M Graf
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes.

Authors:  T Martinsson; A Haegerstrand; C J Dalsgaard
Journal:  Agents Actions       Date:  1993-09

7.  Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot.

Authors:  Wu-Dang Lu; Min-Quan Hui; Jing-Liang Gu; Li Liu; Man-Li Wu; Yi Yang; Yong-Xiao Cao
Journal:  BMC Anesthesiol       Date:  2022-04-21       Impact factor: 2.376

Review 8.  Mechanisms of action of the erector spinae plane (ESP) block: a narrative review.

Authors:  Ki Jinn Chin; Kariem El-Boghdadly
Journal:  Can J Anaesth       Date:  2021-01-06       Impact factor: 6.713

9.  Erector spinae block for postoperative analgesia following axillary hidradenitis suppurativa resection: a case report.

Authors:  Johanna Blair de Haan; Nadia Hernandez; Sudipta Sen
Journal:  Local Reg Anesth       Date:  2018-11-15

10.  Comparison of Epidural Analgesia Using 0.2% Bupivacaine and 0.2% Ropivacaine for the Management of Postoperative Pain in Major Orthopedic Surgery.

Authors:  Sumedha Mehta; Manojkumar Namdeorao Gajbhare; Neha Prabhakar Kamble
Journal:  Anesth Essays Res       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.